Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06723119Not ApplicableRecruiting

Effect of Resveratrol Supplementation on Exercise Performance and Recovery

Role: collaborator

NCT06225440Not ApplicableCompleted

Impact of Levagen+® Palmitoylethanolamide (PEA) in a Cross-Over Trial Examining Stress and Cognition in University Students

Role: collaborator

NCT04465851Not ApplicableCompleted

Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs

Role: collaborator

NCT00502008Not ApplicableCompleted

Effect of Coccinia Cordifolia Extract on Blood Sugar of Newly Diagnosed Diabetics

Role: collaborator

All 4 trials loaded